1. 1574Safety Profile of HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Analysis. (December 2014) Authors: Lalezari, Jacob; Latiff, Gulam H; Brinson, Cynthia; Echevarría, Juan; Treviño-Pérez, Sandra; Bogner, Johannes R; Stock, David; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 540HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis. (December 2014) Authors: Brinson, Cynthia; Lalezari, Jacob; Latiff, Gulam H; Thompson, Melanie; Echevarría, Juan; Treviño-Pérez, Sandra; Stock, David; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial. Issue 1 (January 2016) Authors: Gupta, Samir K; McComsey, Grace A; Lombaard, John; Echevarría, Juan; Orrell, Catherine; Avihingsanon, Anchalee; Osiyemi, Olayemi; Santoscoy, Mario; Ray, Neelanjana; Stock, David A; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Lancet Issue: Volume 3:Issue 1(2016) Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254 . (6th January 2022) Authors: Spinner, Christoph D; Felizarta, Franco; Rizzardini, Giuliano; Philibert, Patrick; Mitha, Essack; Domingo, Pere; Stephan, Christoph J; DeGrosky, Michelle; Bainbridge, Veronica; Zhan, Joyce; Dumitrescu, Teodora Pene; Jeffrey, Jerry L; Xu, Jianfeng; Halliday, Fiona; Gan, Jianjun; Johnson, Mark; Gar... Journal: Clinical infectious diseases Issue: Volume 75:Number 5(2022) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial. Issue 10 (October 2015) Authors: Lalezari, Jacob P; Latiff, Gulam H; Brinson, Cynthia; Echevarría, Juan; Treviño-Pérez, Sandra; Bogner, Johannes R; Thompson, Melanie; Fourie, Jan; Sussmann Pena, Otto A; Mendo Urbina, Fernando C; Martins, Marcelo; Diaconescu, Iulian G; Stock, David A; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Lancet Issue: Volume 2:Issue 10(2015) Page Start: e427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Antiretroviral-Experienced Subjects: Week 48 Analysis of AI438011, a Phase IIb, Randomized Controlled Trial. Issue 3 (April 2017) Authors: Thompson, Melanie; Lalezari, Jacob P; Kaplan, Richard; Pinedo, Yvett; Pena, Otto A Sussmann; Cahn, Pedro; Stock, David A; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Antiviral therapy Issue: Volume 22:Issue 3(2017) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗